Press Release

Mon, Oct 20, 2008

Bone Solutions Inc. appoints orthopedic surgeon, Nancy Lynch, M.D., of Scale Venture

Bone Solutions Inc. appoints orthopedic surgeon, Nancy Lynch, M.D., of Scale Venture Partners to its Scientific Advisory Board

DALLAS--(Business Wire)--

Bone Solutions Inc. (BSI) announced today that it has appointed Nancy Lynch, M.D., to its Scientific Advisory Board, effective immediately. Dr. Lynch is a Principal with Scale Venture Partners, based in Foster City, Calif.

"This addition of Dr. Lynch to our SAB represents an important milestone for BSI, in light of Dr. Lynch's stature as both a distinguished physician and a leading investor in the orthobiologics sector," said Tony Copp, Ph.D., Chief Operating Officer of Bone Solutions Inc.

A Board-certified orthopaedic surgeon, Fellow of the American Academy of Orthopaedic Surgeons (AAOS), and fellowship-trained hand surgeon with several years of clinical practice experience, Dr. Lynch began her career with Orthopedic Healthcare Northwest in Eugene, Ore. Before joining Scale Venture Partners in 2006, she earned her MBA with a concentration in Health Sector Management at Duke University's Fuqua School of Business. She completed her residency, serving as Chief

Resident, at the Mayo Graduate School of Medicine and her fellowship at the Indiana Hand Center. Dr. Lynch graduated from the Washington

University School of Medicine. She holds a BA in Pre-professional Studies and Psychology from the University of Notre Dame and is a member of IrishAngels, Notre Dame's network supporting entrepreneurial endeavors and new venture development.

"Over the last five years, we have seen significant advances in products designed to stimulate bone growth. These products have been

particularly useful for spine surgery, but are gaining traction in other challenging bone healing indications," said Dr. Lynch. "We'll continue to see innovation as we learn more about how patients respond to the products available today. I'm pleased to be joining the BSI Scientific Advisory Board, where I expect to work with the team on the development of the company's product portfolio and provide an orthopaedic surgeon's perspective on current and future product

applications."

About Bone Solutions Inc.

Bone Solutions Inc. ('BSI') has designed its BioHesive(TM) platform as the 'one stop bone-, tendon- and ligament-injectable, biodegradable adhesive technology' for surgeries at hospitals, clinics and other private surgical centers within the orthopaedic industry. The Company believes it is revolutionizing a new solution for orthopaedic surgeons for both human and veterinary uses with a magnesium-based compound that is designed to adhere--for the first time in orthopaedic medical history--bone to bone, as well as

ligaments and tendons to bone. The first application of BioHesive(TM), called OsteoCrete(TM) for human applications, is expected to fill a current void in orthopaedic medical procedures constituting the "next

generation" of bone void filler/cement devices with its bioadhesive, bioabsorbable, biocompatible qualities to more effectively repair, at

lower cost, most non-load-bearing injuries--a potential global market opportunity in excess of $600 million annually. The Company is in the

process of its initial 510(k) filing as a bone void filler for OsteoCrete(TM) with the FDA.

Safe-Harbor Statement

This press release may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. These

forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors

affecting the Company. They are not historical facts, nor are they guarantees of future performance. Because these forward-looking

statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.

Ronald Trahan Associates, Inc.

Ronald Trahan, APR, 508-359-4005, x108

Copyright Business Wire 2008

« Back